Chill Brands Group PLC (LSE: CHLL, OTCQB: CHBRF) is preparing to introduce its nicotine-free Chill ZERO vape products at key locations including WH Smith travel areas, Morrisons stores, and major
Chill Brands Group (AIM:CHLL) Half-year Report for the 6 months to 30 Sep 2023
Chill Brands Group, the international consumer packaged goods company, announces its interim results for the six months ending 30 September 2023 (the “Period”), which can be viewed below and also
Chill Brands Group (LON:CHLL) Trading Statement
Chill Brands, the consumer packaged-goods distribution company, is pleased to provide an update on its trading, focussed on positive developments around its Chill ZERO nicotine-free vapes and the Chill.com marketplace.
The legalization of cannabis in Germany could potentially inspire other European nations, including the UK, to follow in its footsteps.
After Germany’s cabinet greenlit new legislation permitting the recreational use and cultivation of cannabis, predictions have emerged that the rest of Europe, including the UK, may follow suit.
Ananda (AQSE:ANA) Developments Secures Funding for Endometriosis Clinical Trial
Ananda Developments Plc (AQSE: ANA), a developer of cannabinoid medicines, has secured the necessary funding to initiate a trial to test the effectiveness of its cannabidiol oil, MRX1, in treating
Ananda Developments (AQSE:ANA) First Cannabinoid Medicines Launched
Ananda’s ambition is to be a leading provider of high-quality cannabinoid-based medicines for the treatment of complex, chronic inflammatory pain conditions.
Chill Brands (LON:CHLL) broadens its product marketplace at Chill.com.
Chill Brands Group PLC (LSE: CHLL, OTCQB: CHBRF) has recently declared its intent to enlarge the Chill.com product marketplace via a newly inked agreement.
Company Profile (AQSE:ANA) Ananda Developments
Ananda Developments (AQSE: ANA) is an AQUIS-listed healthcare company involved in the development of cannabinoid-based medicines with two concurrently running, third-party funded, Phase II randomised control trials (RCTs).
Cellular Goods PLC – Products to launch on Sephora.co.uk
Cellular Goods (LSE: CBX), a UK-based skincare and wellness company providing premium consumer products formulated with lab-produced cannabinoids, is pleased to announce that it has entered into a contract with
Zak Mir talks to Melissa Sturgess, CEO Ananda Developments
In the wake of the MRX Global acquisition, and what this means for the medical cannabis group
Hellenic Dynamics has entered into an agreement for conducting research on cannabis in Greece.
Hellenic Dynamics Plc (LSE: HELD) has inked a five-year deal with ELGO-DIMITRA, an Institute of Plant Breeding and Genetic Resources located in Greece, to collaborate on research and projects. ELGO-DIMITRA
Love Hemp, the listed cannabis supplements company, said last night that administrators had been appointed.
Love Hemp, the struggling cannabis supplement company, announced last night that administrators were appointed.